ARTICLE | Company News
Humabs BioMed, Novartis deal
July 27, 2015 7:00 AM UTC
Humabs received an undisclosed milestone payment from Novartis under a 2009 deal granting the pharma exclusive rights to use mAbs discovered using Humabs Cellclone platform. The milestone was triggere...